Retail investors own 30% of the US market, but only cast corporate ballots at the same rate. With big stockholders split on ...

A Sinovac Biotech Ltd. minority investor fighting for a $600 million dividend and board changes at the vaccine company is ...

IN CONTRAST, the Reconstituted Imposter Former Board Slate is responsible for the very issues they now claim they’ll resolve. Their unlawful actions triggered the 2019 NASDAQ trading halt and forced ...

The Trump administration is ending U.S. support for immunizations abroad because of its opposition not only to foreign aid, ...

Chinese SinoVac Biotech Ltd. (Nasdaq: SVA) shares have been frozen since 2019 amid shareholder disputes when market cap was ...

The growing incidence of infectious diseases, cancer, and chronic illnesses has substantially increased the demand for ...

Key TakeawaysThe global vaccines market reached USD 87.57 billion in 2024 and is projected to grow to USD 206.78 billion by ...

To no great surprise, the U.K.’s health technology assessment body has found that the benefits of the first two approved Alzheimer’s disease drugs are too small to justify the costs. Neither Kisunla ...

The Board has appointed Geoffrey C. Hsu, CFA, as a director to the Board to fill the vacancy created by such resignation under the laws of Antigua and Barbuda. Mr. Hsu has also been elected as a ...

A ruthless clash for control of Sinovac Biotech (SVA.O), opens new tab, whose vaccine became one of the world’s biggest sellers, has left its stock untradeable on Nasdaq for more than six years. A ...